Results 151 to 160 of about 10,096 (205)

Influence of segmental chromosome abnormalities on survival in children over the age of 12 months with unresectable localised peripheral neuroblastic tumours without MYCN amplification [PDF]

, 2014
Raffaella Defferrari, Katia Mazzocco, I.M. Ambros, Peter F. Ambros, Clare Bedwell, Klaus Beiske, Jean Bénard, Ana P. Berbegall, Nick Bown, Valérie Combaret, Jérôme Couturier, Giovanni Erminio, Claudio Gambini, Alberto Garaventa, Nicole Groß, Riccardo Haupt, J. A. Kohler, Marta Jeison, John Lunec, Bárbara Marques, Tommy Martinsson, Rosa Noguera, Stefano Parodi, Gudrun Schleiermacher, Deborah A. Tweddle, Alexandre Valent, Nadine Van Roy, Aleš Vícha, Eva Villamón, Gian Paolo Tonini   +29 more
openalex   +1 more source

Enlarged and prominent nucleoli may be indicative of MYCN amplification [PDF]

, 2004
Chie Kobayashi, Hector Monforte-Muñoz, Robert B. Gerbing, Daniel O. Stram, Katherine K. Matthay, John N. Lukens, Robert C. Seeger, Hiroyuki Shimada   +7 more
openalex   +1 more source

Diagnostic accuracy of circulating-free DNA for the determination of MYCN amplification status in advanced-stage neuroblastoma: a systematic review and meta-analysis. [PDF]

Br J Cancer, 2020
Trigg RM, Turner SD, Shaw JA, Jahangiri L.   +3 more
europepmc   +1 more source

Table S1 from Extrachromosomal DNA–Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in <i>MYCN</i>-Amplified Cancers

Giulia Montuori, Fengyu Tu, Di Qin, Rachel Schmargon, Elias Rodríguez-Fos, Konstantin Helmsauer, Hui Hui, Susmita Mandal, Karin Purshouse, Lara Fankhänel, Bartolomeo Bosco, Bastiaan Spanjaard, Hannah Seyboldt, Laura Grunewald, Matthias Jürgen Schmitt, Dennis Gürgen, Viktoria Buck, Mathias T. Rosenfeldt, Frank Dubois, Simon Schallenberg, Annika Lehmann, Jessica Theißen, Sabine Taschner‐Mandl, Arend Koch, Patrick Hundsdörfer, Annette Künkele, Angelika Eggert, Matthias Fischer, Gaetano Gargiulo, Teresa G. Krieger, Lukas Chávez, Fabian Coscia, Benjamin Werner, Weini Huang, Anton G. Henssen, Jan R. Dörr   +35 more
openalex   +1 more source

Differential Clinical Significance of Neurotrophin-3 Expression according to MYCN Amplification and TrkC Expression in Neuroblastoma. [PDF]

J Korean Med Sci, 2019
Seo E, Kim JS, Ma YE, Cho HW, Ju HY, Lee SH, Lee JW, Yoo KH, Sung KW, Koo HH.   +9 more
europepmc   +1 more source

Enlarged and prominent nucleoli may be indicative of MYCN amplification : a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index

, 2005
千恵 小林
openalex  

The absence of a novel intron 19-retainingALKtranscript (ALK-I19) andMYCNamplification correlates with an excellent clinical outcome in neuroblastoma patients

, 2018
Abdulraheem Alshareef, Meredith S. Irwin, Nidhi Gupta, Haifeng Zhang, Moinul Haque, Scott D. Findlay, Bo Kyung A. Seong, Justine Lai, Mohammed Rayis, Sadeq Al‐Dandan, Raymond Lai   +10 more
openalex   +2 more sources

Comprehensive evaluation of context dependence of the prognostic impact of MYCN amplification in neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project. [PDF]

Pediatr Blood Cancer, 2019
Campbell K, Shyr D, Bagatell R, Fischer M, Nakagawara A, Nieto AC, Brodeur GM, Matthay KK, London WB, DuBois SG.   +9 more
europepmc   +1 more source

Genetic Instability and Intratumoral Heterogeneity in Neuroblastoma with MYCN Amplification Plus 11q Deletion

, 2013
Eva Villamón, Ana P. Berbegall, Marta Piqueras, Irene Tadeo, Victoria Castel, Anna Djos, Tommy Martinsson, Samuel Navarro, Rosa Noguera   +8 more
openalex   +2 more sources